GNLX
GENELUX CorpCompany with tickers: GNLX
CIK
1231457
CUSIP
36870H103
Shares Outstanding
44,805,811
Price
Holdings
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trading
Congress Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-03-25 | Smalling Ralph | Head of Regulatory | Sell | 240 |
| 2026-03-24 | Smalling Ralph | Head of Regulatory | Sell | 345 |
| 2026-03-24 | Cappello Joseph | Chief Technical Officer | Sell | 906 |
| 2026-03-24 | Yu Yong | SVP, Clinical Development | Sell | 906 |
| 2026-03-24 | Zindrick Thomas | President and CEO | Sell | 3,582 |
| 2026-03-02 | Thomas John | Director | Sell | 10,000 |
| 2026-01-02 | Litten Jason | Chief Medical Officer | Award | 275,000 |
| 2026-01-02 | Litten Jason | Chief Medical Officer | Other | 0 |
| 2025-12-05 | Smalling Ralph | Head of Regulatory | Sell | 165 |
| 2025-12-01 | Thomas John | Director | Sell | 10,000 |
| 2025-11-17 | Yu Yong | SVP, Clinical Development | Sell | 973 |
| 2025-11-17 | Cappello Joseph | Chief Technical Officer | Sell | 973 |
| 2025-11-17 | Zindrick Thomas | President and CEO | Sell | 4,509 |
| 2025-11-17 | Smalling Ralph | Head of Regulatory | Sell | 343 |
| 2025-09-03 | Smalling Ralph | Head of Regulatory | Sell | 580 |
| 2025-09-01 | Cappello Joseph | Chief Technical Officer | Award | 16,666 |
| 2025-09-01 | Cappello Joseph | Chief Technical Officer | Other | 16,666 |
| 2025-09-01 | Zindrick Thomas | President and CEO | Other | 925,000 |
| 2025-09-01 | Zindrick Thomas | President and CEO | Award | 925,000 |
| 2025-09-01 | Yu Yong | SVP, Clinical Development | Other | 207,652 |
| 2025-09-01 | Yu Yong | SVP, Clinical Development | Award | 207,652 |
| 2025-09-01 | Smalling Ralph | Head of Regulatory | Award | 10,000 |
| 2025-09-01 | Smalling Ralph | Head of Regulatory | Other | 8,333 |
| 2025-09-01 | Smalling Ralph | Head of Regulatory | Award | 8,333 |
| 2025-08-27 | Mirabelli Mary | Director | Award | 22,283 |
| 2025-08-27 | Mirabelli Mary | Director | Award | 28,576 |
| 2025-08-27 | Thomas John | Director | Award | 22,283 |
| 2025-08-27 | Thomas John | Director | Award | 28,576 |
| 2025-08-27 | Zindrick Thomas | President and CEO | Award | 478,800 |
| 2025-08-27 | Zindrick Thomas | President and CEO | Award | 361,200 |
| 2025-08-27 | Smalling Ralph | Head of Regulatory | Award | 26,230 |
| 2025-08-27 | Smalling Ralph | Head of Regulatory | Award | 34,770 |
| 2025-08-27 | Smither John W | Director | Award | 28,576 |
| 2025-08-27 | Smither John W | Director | Award | 22,283 |
| 2025-08-27 | Yu Yong | SVP, Clinical Development | Award | 101,480 |
| 2025-08-27 | Yu Yong | SVP, Clinical Development | Award | 134,520 |
| 2025-08-27 | Tyree James L | Director | Award | 22,283 |
| 2025-08-27 | Tyree James L | Director | Award | 28,576 |
| 2025-08-27 | Cappello Joseph | Chief Technical Officer | Award | 107,500 |
| 2025-08-27 | Cappello Joseph | Chief Technical Officer | Award | 142,500 |
| 2025-08-21 | Yu Yong | SVP, Clinical Development | Sell | 3,219 |
| 2025-08-21 | Cappello Joseph | Chief Technical Officer | Sell | 1,270 |
| 2025-08-21 | Zindrick Thomas | President and CEO | Sell | 12,673 |
| 2025-08-21 | Smalling Ralph | Head of Regulatory | Sell | 1,244 |
| 2025-07-01 | Groen Eric | General Counsel | Award | 270,000 |
| 2025-07-01 | Groen Eric | General Counsel | Other | 0 |
| 2025-06-06 | Thomas John | Director | Gift | 25,000 |
| 2025-05-12 | Ryder Sean | General Counsel | Sell | 4,475 |
| 2025-05-12 | Zindrick Thomas | President and CEO | Sell | 10,764 |
| 2025-05-12 | Yu Yong | SVP, Clinical Development | Sell | 5,579 |
| 2025-05-12 | Cappello Joseph | Chief Technical Officer | Sell | 4,737 |
| 2025-05-12 | Smalling Ralph | Head of Regulatory | Sell | 1,259 |
| 2025-03-14 | Smalling Ralph | Head of Regulatory | Award | 4,172 |
| 2025-03-14 | Cappello Joseph | Chief Technical Officer | Award | 13,350 |
| 2025-03-14 | Yu Yong | SVP, Clinical Development | Award | 13,350 |
| 2025-03-14 | Zindrick Thomas | President and CEO | Award | 30,339 |
| 2025-03-14 | Ryder Sean | General Counsel | Award | 10,708 |
| 2025-01-31 | Pulisic Matthew | Chief Financial Officer | Award | 275,000 |
| 2025-01-30 | Pulisic Matthew | Chief Financial Officer | Other | 0 |
| 2024-12-30 | Tyree James L | Director | Sell | 3,460 |
| 2024-12-18 | Ryder Sean | General Counsel | Award | 22,000 |
| 2024-12-18 | Ryder Sean | General Counsel | Award | 30,000 |
| 2024-12-18 | Zak Lourie S. | Chief Financial Officer | Award | 56,525 |
| 2024-12-18 | Zak Lourie S. | Chief Financial Officer | Award | 41,650 |
| 2024-12-18 | Smalling Ralph | Head of Regulatory | Award | 15,525 |
| 2024-12-18 | Smalling Ralph | Head of Regulatory | Award | 21,100 |
| 2024-12-18 | Cappello Joseph | Chief Technical Officer | Award | 29,000 |
| 2024-12-18 | Cappello Joseph | Chief Technical Officer | Award | 39,000 |
| 2024-12-18 | Zindrick Thomas | President and CEO | Award | 134,500 |
| 2024-12-18 | Zindrick Thomas | President and CEO | Award | 183,000 |
| 2024-12-18 | Yu Yong | SVP, Clinical Development | Award | 39,000 |
| 2024-12-18 | Yu Yong | SVP, Clinical Development | Award | 29,000 |
| 2024-12-16 | Zindrick Thomas | President and CEO | Sell | 14,315 |
| 2024-12-16 | Zak Lourie S. | Chief Financial Officer | Sell | 2,103 |
| 2024-12-16 | Smalling Ralph | Head of Regulatory | Sell | 2,510 |
| 2024-12-16 | Cappello Joseph | Chief Technical Officer | Sell | 6,300 |
| 2024-10-18 | Scigalla Paul | Chief Medical Officer | Award | 16,666 |
| 2024-09-13 | Szalay Aladar | 10% Owner | Sell | 33,080 |
| 2024-09-12 | Szalay Aladar | 10% Owner | Other | 5,000 |
| 2024-09-12 | Szalay Aladar | 10% Owner | Sell | 31,777 |
| 2024-09-11 | Szalay Aladar | 10% Owner | Sell | 31,376 |
| 2024-09-11 | Tyree James L | Director | Sell | 1,730 |
| 2024-09-10 | Szalay Aladar | 10% Owner | Sell | 20,384 |
| 2024-09-09 | Szalay Aladar | 10% Owner | Sell | 23,383 |
| 2024-09-09 | Szalay Aladar | 10% Owner | Other | 5,000 |
| 2024-09-03 | Szalay Aladar | 10% Owner | Sell | 42,818 |
| 2024-09-03 | Szalay Aladar | 10% Owner | Other | 5,000 |
| 2024-08-30 | Szalay Aladar | 10% Owner | Sell | 142,589 |
| 2024-08-29 | Szalay Aladar | 10% Owner | Sell | 107,045 |
| 2024-08-28 | Szalay Aladar | 10% Owner | Sell | 15,918 |
| 2024-08-28 | Szalay Aladar | 10% Owner | Other | 5,000 |
| 2024-08-27 | Szalay Aladar | 10% Owner | Sell | 51,630 |
| 2024-08-23 | Szalay Aladar | 10% Owner | Other | 5,000 |
| 2024-08-23 | Szalay Aladar | 10% Owner | Sell | 40,000 |
| 2024-08-01 | Thomas John | Director | Award | 50,469 |
| 2024-08-01 | Thomas John | Director | Award | 39,541 |
| 2024-08-01 | Tyree James L | Director | Award | 39,541 |
| 2024-08-01 | Tyree James L | Director | Award | 50,469 |
| 2024-08-01 | Mirabelli Mary | Director | Award | 39,541 |
| 2024-08-01 | Mirabelli Mary | Director | Award | 50,469 |